{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:49:57Z","timestamp":1793191797357,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M760275"],"award-info":[{"award-number":["2024M760275"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404723"],"award-info":[{"award-number":["82404723"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574403"],"award-info":[{"award-number":["82574403"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.119008","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:28:18Z","timestamp":1779899298000},"page":"119008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Novel aromatic amide Pan-PPAR agonists for dual amelioration of hepatic steatosis and islet dysfunction by promoting cholesterol efflux in the KKAy diabetic mice"],"prefix":"10.1016","volume":"316","author":[{"given":"Ren","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjia","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunwang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2026.119008_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12933-022-01531-7","article-title":"Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China","volume":"21","author":"Yang","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119008_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13098-026-02118-y","article-title":"Low BMI predicts mortality in T2DM older adults: cholesterol parameters demonstrate negative mediation","volume":"18","author":"Mo","year":"2026","journal-title":"Diabetol. Metab. Syndr."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119008_bib3","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.bbadis.2019.04.012","article-title":"Cholesterol metabolism, pancreatic \u03b2-cell function and diabetes","volume":"1865","author":"Perego","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119008_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1172\/JCI33296","article-title":"Cholesterol in islet dysfunction and type 2 diabetes","volume":"118","author":"Brunham","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119008_bib5","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/db07-0056","article-title":"Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic \u03b2-Cell dysfunction","volume":"56","author":"Mingming","year":"2007","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119008_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/biom13020224","article-title":"Cholesterol redistribution in pancreatic \u03b2-Cells: a flexible path to regulate insulin secretion","volume":"13","author":"Galli","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.119008_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.atherosclerosis.2022.05.015","article-title":"Cholesterol crystals drive metabolic reprogramming and M1 macrophage polarisation in primary human macrophages","volume":"352","author":"O'Rourke","year":"2022","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119008_bib8","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaf027","article-title":"Increased steroidogenic acute regulatory protein contributes to cholesterol-induced \u03b2-Cell dysfunction","volume":"166","author":"Akter","year":"2025","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.ejmech.2026.119008_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41569-024-01115-w","article-title":"Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches","volume":"22","author":"Khan","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119008_bib10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejmech.2026.119008_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119008_bib12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmet.2014.02.002","article-title":"Integrated physiology and systems biology of PPAR\u03b1","volume":"3","author":"Kersten","year":"2014","journal-title":"Mol. Metabol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119008_bib13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.58.4.5","article-title":"International union of pharmacology. LXI. Peroxisome proliferator-activated receptors","volume":"58","author":"Michalik","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119008_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-20731-1","article-title":"Fenofibrate differentially activates PPAR\u03b1-mediated lipid metabolism in rat kidney and liver","volume":"15","author":"Pannala","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119008_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11883-020-00897-x","article-title":"Selective peroxisome proliferator-activated receptor alpha modulators (SPPARM\u03b1) in the metabolic syndrome: is pemafibrate light at the end of the tunnel?","volume":"23","author":"Fruchart","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"issue":"Pt 5","key":"10.1016\/j.ejmech.2026.119008_bib16","article-title":"The global perspective on peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) in ectopic fat deposition: a review","volume":"253","author":"Qiu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2026.119008_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/501739","article-title":"Regulation of bile acid and cholesterol metabolism by PPARs","volume":"2009","author":"Li","year":"2009","journal-title":"PPAR Res."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119008_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/hep.20567","article-title":"Troglitazone and liver injury: in search of answers","volume":"41","author":"Chojkier","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2026.119008_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d1309","article-title":"Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies","volume":"342","author":"Loke","year":"2011","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119008_bib20","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1093\/nar\/gkv331","article-title":"The transcriptional PPAR\u03b2\/\u03b4 network in human macrophages defines a unique agonist-induced activation state","volume":"43","author":"Adhikary","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119008_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113535","article-title":"Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: an overview","volume":"221","author":"Villarroel-Vicente","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119008_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.ATV.0000250972.83623.61","article-title":"Activation of PPARbeta\/delta induces endothelial cell proliferation and angiogenesis","volume":"27","author":"Piqueras","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119008_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2020.04.025","article-title":"Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages","volume":"73","author":"Lefere","year":"2020","journal-title":"J. Hepatol."},{"issue":"15","key":"10.1016\/j.ejmech.2026.119008_bib24","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.scib.2021.03.019","article-title":"Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP)","volume":"66","author":"Ji","year":"2021","journal-title":"Sci. Bull. (Beijing)"},{"key":"10.1016\/j.ejmech.2026.119008_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118850","article-title":"Chiglitazar, a PPAR pan-agonist: impacts on type 2 diabetes mellitus and multi-system metabolic regulation - a review","volume":"193","author":"Chang","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"17","key":"10.1016\/j.ejmech.2026.119008_bib26","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"NATIVE study group. A randomized, controlled trial of the Pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119008_bib27","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2024.12.045","article-title":"Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD","volume":"82","author":"Barb","year":"2025","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119008_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/83348","article-title":"PPAR \u03b1 and PPAR-\u03b3 activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway","volume":"7","author":"Chinetti","year":"2001","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119008_bib29","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/meta.2003.50100","article-title":"Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte- derived macrophages","volume":"52","author":"Cabrero","year":"2003","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119008_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/01.ATV.0000252790.70572.0c","article-title":"Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist","volume":"27","author":"Sprecher","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119008_bib31","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1038\/s41467-022-32437-3","article-title":"ABCA1 is an extracellular phospholipid translocase","volume":"13","author":"Segrest","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119008_bib32","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.cmet.2021.09.001","article-title":"Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases","volume":"33","author":"Song","year":"2021","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119008_bib33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nm1546","article-title":"Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment","volume":"13","author":"Brunham","year":"2007","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119008_bib34","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.2337\/db11-0081","article-title":"Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granules","volume":"60","author":"Kruit","year":"2011","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119008_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2337\/db11-1341","article-title":"Loss of both ABCA1 and ABCG1 results in increased disturbances in islet sterol homeostasis, inflammation, and impaired beta-cell function","volume":"61","author":"Kruit","year":"2012","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119008_bib36","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/db11-0944","article-title":"miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets","volume":"61","author":"Wijesekara","year":"2012","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119008_bib37","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.celrep.2017.05.032","article-title":"Hepatocyte ABCA1 deletion impairs liver insulin signaling and lipogenesis","volume":"19","author":"Key","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.119008_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116220","article-title":"A pan-PPAR agonist E17241 ameliorates hyperglycemia and diabetic dyslipidemia in KKAy mice via up-regulating ABCA1 in islet, liver, and white adipose tissue","volume":"172","author":"Sheng","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.119008_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110706","article-title":"Diabetic bladder dysfunction in T2D KK-Ay mice and its changes in the level of relevant gene expression","volume":"131","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119008_bib40","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1530\/eje.0.1390654","article-title":"Genetic analysis of non-insulin dependent diabetes mellitus in KK and KK-Ay mice","volume":"139","author":"Suto S M","year":"1998","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119008_bib41","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s00125-016-3907-6","article-title":"ABCA1 deficiency and cellular cholesterol accumulation increases islet amyloidogenesis in mice","volume":"59","author":"Wijesekara","year":"2016","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119008_bib42","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.str.2007.07.014","article-title":"Partial agonists activate PPARgamma using a helix 12 independent mechanism","volume":"15","author":"Bruning","year":"2007","journal-title":"Structure"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119008_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101727","article-title":"PPAR\u03b1 ligand-binding domain structures with endogenous fatty acids and fibrates","volume":"23","author":"Kamata","year":"2020","journal-title":"iScience"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119008_bib44","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1248\/bpb.34.1631","article-title":"Two thiophenes compounds are partial peroxisome proliferator-activated receptor \u03b1\/\u03b3 dual agonists","volume":"34","author":"Zhihui Zheng","year":"2011","journal-title":"Biol. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119008_bib45","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/1087057108320545","article-title":"Identification of upregulators of human ATP-binding cassette transporter A1 via high-throughput screening of a synthetic and natural compound library","volume":"13","author":"Gao","year":"2008","journal-title":"J. Biomol. Screen"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119008_bib46","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1194\/jlr.M044198","article-title":"Rutaecarpine suppresses atherosclerosis in ApoE-\/- mice through upregulating ABCA1 and SR-BI within RCT","volume":"55","author":"Xu","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejmech.2026.119008_bib47","doi-asserted-by":"crossref","DOI":"10.2337\/db06-S002","article-title":"Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction","volume":"55","author":"Morino","year":"2006","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119008_bib48","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/diabetes.49.3.424","article-title":"Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion","volume":"49","author":"Hohmeier Hm","year":"2000","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119008_bib49","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41467-020-14750-x","article-title":"A molecular switch regulating transcriptional repression and activation of PPARgamma","volume":"11","author":"Shang","year":"2020","journal-title":"Nat. Commun."},{"issue":"6698","key":"10.1016\/j.ejmech.2026.119008_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/25931","article-title":"Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma","volume":"395","author":"Nolte","year":"1998","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.ejmech.2026.119008_bib51","doi-asserted-by":"crossref","first-page":"E2563","DOI":"10.1073\/pnas.1621513114","article-title":"Structural basis for specific ligation of the peroxisome proliferator-activated receptor \u03b4","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:15:31Z","timestamp":1783923331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S0223523426004538"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119008","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel aromatic amide Pan-PPAR agonists for dual amelioration of hepatic steatosis and islet dysfunction by promoting cholesterol efflux in the KKAy diabetic mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119008"}}